Active — Not RecruitingPhase 1/2

NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Australia30 participantsStarted 2022-01-27

Plain-language summary

This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Lens Densitometry

Timeframe: 6 months

NCT IDNCT05026632

SponsorNacuity Pharmaceuticals, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-09